![](/img/cover-not-exists.png)
SO052EFFECT OF SEVERE RENAL IMPAIRMENT OR END-STAGE RENAL DISEASE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ROXADUSTAT, AN ORAL HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR
Groenendaal-van de Meent, Dorien, Kerbusch, Virginie, Kaspera, Rudiger, Barroso-Fernandez, Begona, Galletti, Piergiorgio, Klein, Gernot K, Den Adel, MartinVolume:
35
Journal:
Nephrology Dialysis Transplantation
DOI:
10.1093/ndt/gfaa139.so052
Date:
June, 2020
File:
PDF, 100 KB
2020